Search results for the GEO ID: GSE22779
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM563241
GPL570
Epilepsy patient E3, untreated sample Mononuclear cells, epilepsy patient E3, before administration of GC tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: untreated treatment_time: 0 hrs patient: E3 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 before administration of GC. E3-0h
GSM563242
GPL570
Epilepsy patient E3, 2 hours GC treatment Mononuclear cells, epilepsy patient E3, 2 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 2 hrs patient: E3 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 taken 2 hours after GC administration. E3-2h
GSM563243
GPL570
Epilepsy patient E3, 6 hours GC treatment Mononuclear cells, epilepsy patient E3, 6 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 6 hrs patient: E3 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 taken 6 hours after GC administration. E3-6h
GSM563244
GPL570
Epilepsy patient E3, 24 hours GC treatment Mononuclear cells, epilepsy patient E3, 24 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 24 hrs patient: E3 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E3 taken 24 hours after GC administration. E3-24h
GSM563245
GPL570
Epilepsy patient E4, untreated sample Mononuclear cells, epilepsy patient E4, before administration of GC tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: untreated treatment_time: 0 hrs patient: E4 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 before administration of GC. E4-0h
GSM563246
GPL570
Epilepsy patient E4, 2 hours GC treatment Mononuclear cells, epilepsy patient E4, 2 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 2 hrs patient: E4 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 2 hours after GC administration. E4-2h
GSM563247
GPL570
Epilepsy patient E4, 6 hours GC treatment Mononuclear cells, epilepsy patient E4, 6 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 6 hrs patient: E4 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 6 hours after GC administration. E4-6h
GSM563248
GPL570
Epilepsy patient E4, 24 hours GC treatment Mononuclear cells, epilepsy patient E4, 24 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 24 hrs patient: E4 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E4 taken 24 hours after GC administration. E4-24h
GSM563249
GPL570
Epilepsy patient E5, untreated sample Mononuclear cells, epilepsy patient E5, before administration of GC tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: untreated treatment_time: 0 hrs patient: E5 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 before administration of GC. E5-0h
GSM563250
GPL570
Epilepsy patient E5, 2 hours GC treatment Mononuclear cells, epilepsy patient E5, 2 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 2 hrs patient: E5 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 taken 2 hours after GC administration. E5-2h
GSM563251
GPL570
Epilepsy patient E5, 6 hours GC treatment Mononuclear cells, epilepsy patient E5, 6 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 6 hrs patient: E5 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 taken 6 hours after GC administration. E5-6h
GSM563252
GPL570
Epilepsy patient E5, 24 hours GC treatment Mononuclear cells, epilepsy patient E5, 24 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: epilepsy, non-leukemic treatment: dexamethasone treatment_time: 24 hrs patient: E5 Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of the epilepsy patient E5 taken 24 hours after GC administration. E5-24h
GSM563253
GPL570
Healthy donor, untreated sample Mononuclear cells, healthy donor, before administration of GC tissue: peripheral blood cell type: mononuclear cells disease state: healthy treatment: untreated treatment_time: 0 hrs Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor before administration of GC. RPK-II-0h
GSM563254
GPL570
Healthy donor, 2 hours GC treatment Mononuclear cells, healthy donor, 2 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: healthy treatment: dexamethasone treatment_time: 2 hrs Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor taken 2 hours after GC administration. RPK-II-2h
GSM563255
GPL570
Healthy donor, 6 hours GC treatment Mononuclear cells, healthy donor, 6 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: healthy treatment: dexamethasone treatment_time: 6 hrs Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor taken 6 hours after GC administration. RPK-II-6h
GSM563256
GPL570
Healthy donor, 24 hours GC treatment Mononuclear cells, healthy donor, 24 hours after GC administration tissue: peripheral blood cell type: mononuclear cells disease state: healthy treatment: dexamethasone treatment_time: 24 hrs Gene expression of mononuclear cells isolated from the peripheral blood (using Lymphoprep) of a healthy donor taken 24 hours after GC administration. RPK-II-24h
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes